J. Goldman & Co’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-293,961
| Closed | -$785K | – | 312 |
|
2025
Q1 | $785K | Buy |
293,961
+269,413
| +1,097% | +$719K | 0.02% | 244 |
|
2024
Q4 | $86.4K | Hold |
24,548
| – | – | ﹤0.01% | 304 |
|
2024
Q3 | $116K | Hold |
24,548
| – | – | ﹤0.01% | 307 |
|
2024
Q2 | $115K | Hold |
24,548
| – | – | ﹤0.01% | 289 |
|
2024
Q1 | $112K | Sell |
24,548
-42,953
| -64% | -$195K | ﹤0.01% | 261 |
|
2023
Q4 | $278K | Buy |
+67,501
| New | +$278K | 0.01% | 185 |
|
2013
Q4 | – | Sell |
-40
| Closed | -$811K | – | 126 |
|
2013
Q3 | $811K | Sell |
40
-61
| -60% | -$1.24M | 0.08% | 124 |
|
2013
Q2 | $2.18M | Buy |
+101
| New | +$2.18M | 0.22% | 86 |
|